Compare · AZZ vs EW
AZZ vs EW
Side-by-side comparison of AZZ Inc. (AZZ) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.
Summary
- AZZ operates in Industrials, while EW operates in Health Care - the two are in different parts of the market.
- EW is the larger of the two at $50.41B, about 11.6x AZZ ($4.33B).
- Over the past year, AZZ is up 54.0% and EW is up 13.9% - AZZ leads by 40.1 points.
- EW has been more active in the news (7 items in the past 4 weeks vs 6 for AZZ).
- EW has more recent analyst coverage (25 ratings vs 14 for AZZ).
- Company
- AZZ Inc.
- Edwards Lifesciences Corporation
- Price
- $141.78-1.41%
- $86.35-1.32%
- Market cap
- $4.33B
- $50.41B
- 1M return
- -4.63%
- +11.90%
- 1Y return
- +53.97%
- +13.87%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 7
- Recent ratings
- 14
- 25
AZZ Inc.
AZZ Inc. provides galvanizing and metal coating solutions, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, refining, and industrial markets in the United States and internationally. The company operates through two segments, Infrastructure Solutions and Metal Coatings. The Metal Coatings segment offers hot dip galvanizing, powder coating, anodizing, plating, and other metal coating applications to the steel fabrication and other industries. It serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. The Infrastructure Solutions segment provides products and services to support industrial and electrical applications. It offers custom switchgear, electrical enclosures, medium and high voltage bus ducts, explosion proof and hazardous duty lighting, nuclear safety-related equipment, and tubular products, as well as solutions and engineering resources to multi-national companies and small independent companies. This segment sells its products through internal sales force, manufacturers' representatives, distributors, and agents. The company was incorporated in 1956 and is headquartered in Fort Worth, Texas.
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest AZZ
- Chief Financial Officer Crawford Jason converted options into 1,825 shares and covered exercise/tax liability with 717 shares, increasing direct ownership by 6% to 19,825 units (SEC Form 4) to satisfy withholding tax
- COO - Metal Coatings Stovall Bryan Lee converted options into 9,129 shares and covered exercise/tax liability with 3,592 shares, increasing direct ownership by 17% to 37,677 units (SEC Form 4) (for tax liability)
- AZZ Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by AZZ Inc.
- SEC Form DEF 14A filed by AZZ Inc.
- AZZ Inc. Announces June Investor Conference Schedule
- AZZ Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- President-Metal Coatings Bella Todd Michael converted options into 4,582 shares and covered exercise/tax liability with 1,494 shares, increasing direct ownership by 92% to 6,440 units (SEC Form 4) to satisfy tax liability
- Chief Financial Officer Crawford Jason converted options into 8,429 shares and covered exercise/tax liability with 3,315 shares, increasing direct ownership by 38% to 18,717 units (SEC Form 4) (for tax liability)
- Pres & COO - Precoat Metals Vellines Jeffrey converted options into 6,997 shares and covered exercise/tax liability with 3,121 shares, increasing direct ownership by 180% to 6,032 units (SEC Form 4) to cover withholding tax
Latest EW
- SEC Form 3 filed by new insider Mistras Theodora
- SVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)
- SEC Form SD filed by Edwards Lifesciences Corporation
- CVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)
- CEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)
- CVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)